Company
Concerto Biosciences
Scaled, structured data to convert microbial ecology into consumer health products.
Also known as Concerto Biosciences, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- Legal name
- Concerto Biosciences, Inc.
- concertobio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We built the largest microbial interaction dataset in the world. Powerful, multifunctional microbe-based ingredients now stand out in plain view.
Funding snapshot
- Total raised
- $24.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $23M2022-11-02
Funding rounds
- Series A
- $23M2022-11-02, Company stated
- Round, 2022
- $24.5M2022-03-08, SEC form D sold, 37 investors
Products
- Other
- CB-0XX
- Web
- CB-0XX
- Other
- ENS-002 (Fermata Derm)
- Web
- ENS-002 (Fermata Derm)
- Other
- ENS-003
- Web
- ENS-003
Loading relationship preview